These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 12642462

  • 1. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.
    Tam D, Tirona RG, Pang KS.
    Drug Metab Dispos; 2003 Apr; 31(4):373-83. PubMed ID: 12642462
    [Abstract] [Full Text] [Related]

  • 2. A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism.
    Cong D, Doherty M, Pang KS.
    Drug Metab Dispos; 2000 Feb; 28(2):224-35. PubMed ID: 10640522
    [Abstract] [Full Text] [Related]

  • 3. PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism.
    Fan J, Chen S, Chow EC, Pang KS.
    Curr Drug Metab; 2010 Nov; 11(9):743-61. PubMed ID: 21189137
    [Abstract] [Full Text] [Related]

  • 4. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS, Chow EC.
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [Abstract] [Full Text] [Related]

  • 5. Theoretical consideration of the properties of intestinal flow models on route-dependent drug removal: Segregated Flow (SFM) vs. Traditional (TM).
    Noh K, Pang KS.
    Biopharm Drug Dispos; 2019 May; 40(5-6):195-213. PubMed ID: 31099032
    [Abstract] [Full Text] [Related]

  • 6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):679-98. PubMed ID: 23727464
    [Abstract] [Full Text] [Related]

  • 7. A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model.
    Ando H, Hisaka A, Suzuki H.
    Drug Metab Dispos; 2015 Apr 16; 43(4):590-602. PubMed ID: 25616403
    [Abstract] [Full Text] [Related]

  • 8. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS, Maeng HJ, Fan J.
    Mol Pharm; 2009 Apr 16; 6(6):1734-55. PubMed ID: 19891494
    [Abstract] [Full Text] [Related]

  • 9. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
    Deng J, Jhandey A, Zhu X, Yang Z, Yik KFP, Zuo Z, Lam TN.
    PLoS One; 2018 Apr 16; 13(8):e0203361. PubMed ID: 30169515
    [Abstract] [Full Text] [Related]

  • 10. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
    Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, Yu LX, Sun D.
    Pharm Res; 2006 Aug 16; 23(8):1675-86. PubMed ID: 16841194
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Why we need proper PBPK models to examine intestine and liver oral drug absorption.
    Chow EC, Pang KS.
    Curr Drug Metab; 2013 Jan 16; 14(1):57-79. PubMed ID: 22935069
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration.
    Chiou WL.
    Int J Clin Pharmacol Ther; 1994 Sep 16; 32(9):474-82. PubMed ID: 7820330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y, Maeda K, Ikejiri K, Yoshida K, Horie T, Sugiyama Y.
    Biopharm Drug Dispos; 2013 Jan 16; 34(1):45-78. PubMed ID: 23115084
    [Abstract] [Full Text] [Related]

  • 20. Interaction of Drug or Food with Drug Transporters in Intestine and Liver.
    Nakanishi T, Tamai I.
    Curr Drug Metab; 2015 Jan 16; 16(9):753-64. PubMed ID: 26630906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.